J. Goldman & Co LP

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
362
Total Value
2717381560
Accession Number
0001085146-25-003196
Form Type
13F-HR
Manager Name
J. Goldman & Co LP
Data Enrichment
89% identified
322 identified40 unidentified

Holdings

362 positions
Manager:
Search and click to pin securities to the top
Page 17 of 19
Avidity Biosciences, Inc.
Shares:
13600(+0.0%)
Value:
$401.5M(+1.5%)
Black Diamond Therapeutics, Inc.
Shares:
256499
Value:
$397.6M
464288240
Shares:
7000
Value:
$388.1M
PVH CORP. /DE/
Shares:
5900(-94.1%)
Value:
$381.4M(-96.4%)
Immunovant, Inc.
Shares:
20400(-40.6%)
Value:
$348.6M(-59.0%)
M8001Q126
Shares:
128483(+0.0%)
Value:
$348.2M(-10.8%)
CATALYST PHARMACEUTICALS, INC.
Shares:
13496(-0.0%)
Value:
$327.3M(+16.2%)
TG THERAPEUTICS, INC.
Shares:
8036(+0.0%)
Value:
$316.9M(+31.0%)
Affirm Holdings, Inc.
Shares:
6970
Value:
$315.0M
Revolve Group, Inc.
Shares:
14028(-34.8%)
Value:
$301.5M(-58.1%)
GROUP 1 AUTOMOTIVE INC
Shares:
760(-92.5%)
Value:
$290.3M(-93.2%)
92189F106
Shares:
6000
Value:
$275.8M
Duolingo, Inc.
Shares:
831
Value:
$258.1M
Upstart Holdings, Inc.
Shares:
5500
Value:
$253.2M
ETSY INC
Shares:
5000
Value:
$235.9M
Okta, Inc.
Shares:
2240
Value:
$235.7M
Toast, Inc.
Shares:
7042(-96.6%)
Value:
$233.6M(-96.9%)
ROKU, INC
Shares:
3000(-99.2%)
Value:
$211.3M(-99.2%)
MediWound Ltd.
Shares:
13070(-77.8%)
Value:
$202.8M(-80.7%)
Terns Pharmaceuticals, Inc.
Shares:
67500(-71.4%)
Value:
$186.3M(-85.7%)